Autoimmune Diseases of the Nervous System  >>  otilimab (GSK3196165)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
otilimab (GSK3196165) / GSK
NCT01517282: Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis

Checkmark For multiple sclerosis
Sep 2014 - Sep 2014: For multiple sclerosis
Completed
1/2
32
Europe
MOR103, Placebo
MorphoSys AG
Multiple Sclerosis
01/14
02/14

Download Options